Published in Aliment Pharmacol Ther on February 01, 1999
Peginterferon alfa-2a in patients with chronic hepatitis C. N Engl J Med (2000) 5.58
Intramolecular integration within Moloney murine leukemia virus DNA. J Virol (1981) 3.77
Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis. N Engl J Med (2000) 3.74
Garlic or jalapeño peppers for treatment of Helicobacter pylori infection. Am J Gastroenterol (1999) 2.77
Point mutations in the 23S rRNA gene of Helicobacter pylori associated with different levels of clarithromycin resistance. J Antimicrob Chemother (1997) 2.47
Relationship between the cagA 3' repeat region of Helicobacter pylori, gastric histology, and susceptibility to low pH. Gastroenterology (1999) 2.44
Demonstration of unexpected antibiotic resistance of genotypically identical Helicobacter pylori isolates. Clin Infect Dis (1998) 2.38
Intravenous regional block using ketorolac: preliminary results in the treatment of reflex sympathetic dystrophy. Anesth Analg (1992) 2.13
Detection of perchlorate and the soluble chemistry of martian soil at the Phoenix lander site. Science (2009) 2.01
Molecular epidemiology of Helicobacter pylori: separation of H. pylori from East Asian and non-Asian countries. Epidemiol Infect (2000) 1.97
Detection of Mycobacterium avium subspecies paratuberculosis in Crohn's diseased tissues by in situ hybridization. Am J Gastroenterol (2001) 1.93
Sulphation of colonic and rectal mucin in inflammatory bowel disease: reduced sulphation of rectal mucus in ulcerative colitis. Clin Sci (Lond) (1992) 1.88
Dose escalation in chemoradiation for anal cancer: preliminary results of RTOG 92-08. Cancer J Sci Am (2006) 1.86
Analysis of metronidazole, clarithromycin and tetracycline resistance of Helicobacter pylori isolates from Korea. J Antimicrob Chemother (2001) 1.68
Etiology of Crohn's disease: the role of Mycobacterium avium paratuberculosis. Trends Mol Med (2001) 1.65
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
Challenge model for Helicobacter pylori infection in human volunteers. Gut (2004) 1.57
Sequential therapy using high-dose esomeprazole-amoxicillin followed by gatifloxacin for Helicobacter pylori infection. Aliment Pharmacol Ther (2006) 1.54
Review article: Mycobacterium avium subsp. paratuberculosis as one cause of Crohn's disease. Aliment Pharmacol Ther (2001) 1.54
Internal mammary node irradiation neither decreases distant metastases nor improves survival in stage I and II breast cancer. Int J Radiat Oncol Biol Phys (2000) 1.52
Twice daily (mid-day and evening) quadruple therapy for H. pylori infection in the United States. Dig Liver Dis (2004) 1.51
Detection of Helicobacter pylori by rapid urease tests: is biopsy size a critical variable? Gastrointest Endosc (1996) 1.51
Stimulation of the human immunodeficiency virus type 1 enhancer by the human T-cell leukemia virus type I tax gene product involves the action of inducible cellular proteins. J Virol (1989) 1.49
Mutation affecting thermostability of sigma subunit of Escherichia coli RNA polymerase lies near the dnaG locus at about 66 min on the E. coli genetic map. Proc Natl Acad Sci U S A (1978) 1.48
Brachial plexus block with a new local anaesthetic: 0.5 per cent ropivacaine. Can J Anaesth (1990) 1.44
The effects of freezing and antibiotics on the viability of Acanthamoeba cysts. Arch Ophthalmol (1989) 1.42
Effects of cytokines from activated immune cells on vascular cell growth and HIV-1 gene expression. Implications for AIDS-Kaposi's sarcoma pathogenesis. J Immunol (1992) 1.42
Analysis of rdxA and involvement of additional genes encoding NAD(P)H flavin oxidoreductase (FrxA) and ferredoxin-like protein (FdxB) in metronidazole resistance of Helicobacter pylori. Antimicrob Agents Chemother (2000) 1.42
Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41
Intraoperative ultrasound does not improve detection of liver metastases in resectable pancreatic cancer. Am J Surg (1998) 1.41
Comparison of agar gel (CLOtest) or reagent strip (PyloriTek) rapid urease tests for detection of Helicobacter pylori infection. Am J Gastroenterol (1997) 1.40
Isolation of Helicobacter pylori from sheep-implications for transmission to humans. Am J Gastroenterol (2001) 1.40
Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7 TeV. Phys Rev Lett (2011) 1.39
Amoxycillin tolerance in Helicobacter pylori. J Antimicrob Chemother (1999) 1.38
Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34
Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32
Origin of the magnetoelectric coupling effect in Pb(Zr0.2Ti0.8)O{3}/La{0.8}Sr{0.2}MnO{3} Multiferroic heterostructures. Phys Rev Lett (2010) 1.32
Patients with early stage invasive cancer with close or positive margins treated with conservative surgery and radiation have an increased risk of breast recurrence that is delayed by adjuvant systemic therapy. Int J Radiat Oncol Biol Phys (1999) 1.29
Prognostic value of CA 19-9 levels in patients with carcinoma of the pancreas treated with radiotherapy. Int J Radiat Oncol Biol Phys (1998) 1.28
Observation of associated near-side and away-side long-range correlations in sqrt[s(NN)]=5.02 TeV proton-lead collisions with the ATLAS detector. Phys Rev Lett (2013) 1.27
Normative model for cold pressor test. Am J Phys Med Rehabil (1989) 1.26
Plasma concentrations of ropivacaine given with or without epinephrine for brachial plexus block. Can J Anaesth (1990) 1.23
Search for dark matter candidates and large extra dimensions in events with a photon and missing transverse momentum in pp collision data at sqrt[s]=7 TeV with the ATLAS detector. Phys Rev Lett (2013) 1.19
Isolation and characterization of tetracycline-resistant clinical isolates of Helicobacter pylori. Antimicrob Agents Chemother (2000) 1.19
Regional differences in metronidazole resistance and increasing clarithromycin resistance among Helicobacter pylori isolates from Japan. Antimicrob Agents Chemother (2000) 1.18
Effectiveness of HIV risk reduction initiatives among out-of-treatment non-injection drug users. J Psychoactive Drugs (1999) 1.17
Citric acid as the test meal for the 13C-urea breath test. Am J Gastroenterol (1999) 1.17
Activation of human serum complement by bacterial lipopolysaccharides: structural requirements for antibody independent activation of the classical and alternative pathways. Mol Immunol (1987) 1.16
Pharmacokinetics of low-dose methotrexate in rheumatoid arthritis patients. J Pharm Sci (1989) 1.16
The rhythmic structure of mother-infant interaction in term and preterm infants. Child Dev (1985) 1.14
Search for a supersymmetric partner to the top quark in final states with jets and missing transverse momentum at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.13
Biological markers of risk in nipple aspirate fluid are associated with residual cancer and tumour size. Br J Cancer (1999) 1.13
Rapid diagnosis of Acanthamoeba keratitis using calcofluor white. Arch Ophthalmol (1986) 1.13
Conservation of Helicobacter pylori genotypes in different ethnic groups in Houston, Texas. J Infect Dis (2000) 1.12
H2O at the Phoenix landing site. Science (2009) 1.12
DNA sequence analysis of rdxA and frxA from 12 pairs of metronidazole-sensitive and -resistant clinical Helicobacter pylori isolates. Antimicrob Agents Chemother (2001) 1.11
QT dispersion and arrhythmic events in idiopathic dilated cardiomyopathy. Am J Cardiol (1996) 1.11
A comparison of ropivacaine 0.5% and bupivacaine 0.5% for brachial plexus block. Anesthesiology (1991) 1.10
Fas-deficient lpr mice are more susceptible to graft-versus-host disease. J Immunol (2000) 1.09
Corticosteroids in COPD. A clinical trial and reassessment of the literature. Chest (1986) 1.09
Furazolidone combination therapies for Helicobacter pylori infection in the United States. Aliment Pharmacol Ther (2000) 1.09
Phase I trial of buthionine sulfoximine in combination with melphalan in patients with cancer. J Clin Oncol (1996) 1.07
Search for tb resonances in proton-proton collisions at √s=7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.07
Influence of endoscopic biopsy forceps characteristics on tissue specimens: results of a prospective randomized study. Gastrointest Endosc (1999) 1.06
A new method for covalent coupling of heparin and other glycosaminoglycans to substances containing primary amino groups. Carbohydr Res (1983) 1.06
Predictors of survival in patients with systemic light-chain amyloidosis and cardiac involvement initially ineligible for stem cell transplantation and treated with oral melphalan and dexamethasone. Br J Haematol (2008) 1.06
Preoperative chemoradiation for adenocarcinoma of the pancreas and duodenum. Int J Radiat Oncol Biol Phys (1994) 1.05
Bacterial contamination of eyedrop dispensers. Am J Ophthalmol (1984) 1.05
Search for a light Higgs boson decaying to long-lived weakly interacting particles in proton-proton collisions at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.05
Best practice in primary care pathology: review 2. J Clin Pathol (2006) 1.05
Furazolidone- and nitrofurantoin-resistant Helicobacter pylori: prevalence and role of genes involved in metronidazole resistance. Antimicrob Agents Chemother (2001) 1.04
HIV prevention protocols: adaptation to evolving trends in drug use. J Psychoactive Drugs (1999) 1.04
Intravenous regional guanethidine in the treatment of reflex sympathetic dystrophy/causalgia: a randomized, double-blind study. Guanethidine Study Group. Anesth Analg (1995) 1.03
Early events in proton pump inhibitor-associated exacerbation of corpus gastritis. Aliment Pharmacol Ther (2003) 1.03
Ecological momentary assessment of temptation and lapse in dieting. Eat Behav (2001) 1.03
Inaccuracies in using the lumpectomy scar for planning electron boosts in primary breast carcinoma. Int J Radiat Oncol Biol Phys (1994) 1.03
Identification of cell wall deficient forms of M. avium subsp. paratuberculosis in paraffin embedded tissues from animals with Johne's disease by in situ hybridization. J Microbiol Methods (2000) 1.02
Nitric oxide synthase and postischemic liver injury. Biochem Biophys Res Commun (2000) 1.02
Insulin adsorbance to polyvinylchloride surfaces with implications for constant-infusion therapy. Diabetes (1976) 1.02
Immunologic activity of lipopolysaccharides released from macrophages after the uptake of intact E. coli in vitro. J Immunol (1986) 1.00
Helicobacter pylori in sheep milk. Lancet (1999) 1.00
Homelessness and gender in out-of-treatment drug users. Am J Drug Alcohol Abuse (2000) 1.00
Search for supersymmetry in events with three leptons and missing transverse momentum in √[s]=7 TeV pp collisions with the ATLAS detector. Phys Rev Lett (2012) 0.99
In vivo studies of DNA synthesis in human normal and tumor cells. Cancer Res (1967) 0.99
A comparative study of 0.25% ropivacaine and 0.25% bupivacaine for brachial plexus block. Anesth Analg (1992) 0.99
Estimating creatinine clearance in elderly patients with low serum creatinine concentrations. Am J Hosp Pharm (1994) 0.98
A closed rebreathing system for dose maintenance during Partial Liquid Ventilation. Biomed Instrum Technol (1999) 0.97
Sonography and computed tomography in the diagnosis of carcinoma of the gallbladder. AJR Am J Roentgenol (1984) 0.97
Rural hospitals and the local economy: a needed extension and refinement of existing empirical research. J Rural Health (1999) 0.97
Structural studies of the O-specific side-chains of the lipopolysaccharide from Yersinia enterocolitica Ye 128. Carbohydr Res (1980) 0.96
Frameshift mutations in rdxA and metronidazole resistance in North American Helicobacter pylori isolates. J Antimicrob Chemother (2000) 0.96
Meta-analysis: proton pump inhibitor or H2-receptor antagonist for Helicobacter pylori eradication. Aliment Pharmacol Ther (2003) 0.96
A nonsense mutation in the apolipoprotein C-IIPadova gene in a patient with apolipoprotein C-II deficiency. J Clin Invest (1989) 0.96
Adriamycin chemotherapy for malignant mixed mesodermal tumor of the ovary. A Gynecologic Oncology Group Study. Am J Clin Oncol (1986) 0.95
A rapid liquid chromatographic determination of S-adenosylhomocysteine in subgram amounts of tissue. Anal Biochem (1975) 0.95
In situ hybridization method for studies of cell wall deficient M. paratuberculosis in tissue samples. Vet Microbiol (2000) 0.95
Syncope recurrence can better be predicted by history than by head-up tilt testing in untreated patients with suspected neurally mediated syncope. Eur Heart J (1997) 0.95